Digital Therapeutics and Wellness Market is Booming Worldwide with Proteus Digital Health, Omada Health, Welldoc
Digital Therapeutics and Wellness Market is Booming Worldwide with Proteus Digital Health, Omada Health, Welldoc
Stay updated with breaking news from Proteus Digital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Digital Therapeutics and Wellness Market is Booming Worldwide with Proteus Digital Health, Omada Health, Welldoc
The United States government is the single largest purchaser of psychotropic drugs in the world by far. As a citizenry, we have to ask: Why?
The approval of the digital antipsychotic may open the door for more pharmaceutical company profits without evidence of benefits to patients.
Share Otsuka Pharmaceutical and Click Therapeutics have announced the launch of a new, fully remote clinical trial being conducted on Verily's Project Baseline platform. Called the Mirai study, it will be measuring a digital therapeutics intervention's effectiveness in reducing symptoms of depression among adults who have a major depressive disorder (MDD) diagnosis and are on antidepressant monotherapy. Christoph Koenen, EVP and chief medical officer of Ostuka Pharmaceutical Companies U.S., told MobiHealthNews that the pivotal, randomized, controlled trial will enroll as many as 540 pa...